Scholarlink

Background <p>To investigate the effects of different topical non-steroidal anti-inflammatory drugs (NSAIDs) and demographic characteristics on pain perception associated with panretinal photocoagulation.</p> Methods <p>Before panretinal photocoagulation, patients received one of seven topical NSAIDs, while the control group received artificial tears. Following panretinal photocoagulation, subjective pain was assessed using the visual analogue scale. The impact of demographic factors and NSAID type on visual analogue scale scores was statistically analysed. Demographic data were compared using the Mann-Whitney U test and NSAID groups with one-way ANOVA.</p> Results <p>The study included 270 eyes from 270 patients. No significant differences were observed among NSAID groups regarding age, gender, diabetes duration, diabetic retinopathy type, number of intravitreal injections, panretinal photocoagulation sessions, or photocoagulation energy. In all participants, pain perception was higher in females (<i>p</i> &lt; 0.001), patients aged ≤ 60 years (<i>p</i> &lt; 0.001), and those with proliferative diabetic retinopathy (<i>p</i> &lt; 0.001). Bromfenac (<i>p</i> &lt; 0.001), indomethacin (<i>p</i> &lt; 0.001), nepafenac 0.3% (<i>p</i> = 0.002), and diclofenac (<i>p</i> = 0.029) significantly reduced pain, whereas ketorolac trometamol, nepafenac 0.1%, and flurbiprofen did not. Among the effective NSAIDs, nepafenac 0.3% and diclofenac were ineffective in males, while diclofenac showed no efficacy in patients over 60 years of age or those with proliferative diabetic retinopathy. No NSAID demonstrated a significant effect in non-proliferative diabetic retinopathy patients.</p> Conclusions <p>Bromfenac and indomethacin demonstrate consistent analgesic efficacy in nearly all patients with panretinal photocoagulation-related pain, while nepafenac 0.3% and diclofenac are effective in a majority of cases. However, heightened panretinal photocoagulation-related pain in females, patients aged ≤ 60 years and those with proliferative diabetic retinopathy may necessitate careful consideration in these populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Analgesic efficacy of 7 different topical NSAIDs in panretinal photocoagulation-associated pain

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月2日

查看全文
  • Ahmet Kürşad Sakallıoğlu,
  • Tülay Engi̇n,
  • Tuğçe Bek,
  • Hande Güçlü

摘要

Background

To investigate the effects of different topical non-steroidal anti-inflammatory drugs (NSAIDs) and demographic characteristics on pain perception associated with panretinal photocoagulation.

Methods

Before panretinal photocoagulation, patients received one of seven topical NSAIDs, while the control group received artificial tears. Following panretinal photocoagulation, subjective pain was assessed using the visual analogue scale. The impact of demographic factors and NSAID type on visual analogue scale scores was statistically analysed. Demographic data were compared using the Mann-Whitney U test and NSAID groups with one-way ANOVA.

Results

The study included 270 eyes from 270 patients. No significant differences were observed among NSAID groups regarding age, gender, diabetes duration, diabetic retinopathy type, number of intravitreal injections, panretinal photocoagulation sessions, or photocoagulation energy. In all participants, pain perception was higher in females (p < 0.001), patients aged ≤ 60 years (p < 0.001), and those with proliferative diabetic retinopathy (p < 0.001). Bromfenac (p < 0.001), indomethacin (p < 0.001), nepafenac 0.3% (p = 0.002), and diclofenac (p = 0.029) significantly reduced pain, whereas ketorolac trometamol, nepafenac 0.1%, and flurbiprofen did not. Among the effective NSAIDs, nepafenac 0.3% and diclofenac were ineffective in males, while diclofenac showed no efficacy in patients over 60 years of age or those with proliferative diabetic retinopathy. No NSAID demonstrated a significant effect in non-proliferative diabetic retinopathy patients.

Conclusions

Bromfenac and indomethacin demonstrate consistent analgesic efficacy in nearly all patients with panretinal photocoagulation-related pain, while nepafenac 0.3% and diclofenac are effective in a majority of cases. However, heightened panretinal photocoagulation-related pain in females, patients aged ≤ 60 years and those with proliferative diabetic retinopathy may necessitate careful consideration in these populations.